Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

CEL-SCI Corporation (CVM)

13.96   -0.16 (-1.13%) 01-24 16:00
Open: 14.51 Pre. Close: 14.12
High: 15 Low: 13.39
Volume: 1,307,542 Market Cap: 494M
CEL-SCI Corp is a biotechnology company. It is engaged in the research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.012 - 15.088 15.088 - 15.137
Low: 13.224 - 13.316 13.316 - 13.375
Close: 13.823 - 13.967 13.967 - 14.059

Technical analysis

as of: 2020-01-24 4:30:53 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 17.52     One year: 20.46
Support: Support1: 10.28    Support2: 7.36
Resistance: Resistance1: 15.00    Resistance2: 17.52
Pivot: 10.09
Moving Average: MA(5): 12.84     MA(20): 9.77
MA(100): 8.28     MA(250): 6.67
MACD: MACD(12,26): 1.29     Signal(9): 0.70
Stochastic oscillator: %K(14,3): 90.92     %D(3): 93.00
RSI: RSI(14): 80.18
52-week: High: 15.00  Low: 2.37  Change(%): 407.6
Average Vol(K): 3-Month: 68169  10-Days: 151990

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CVM has closed below upper band by 6.2%. Bollinger Bands are 359.8% wider than normal. The large width of the bands suggest high volatility as compared to CVM's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue.

Headline News

CVR Medical : Provides Corporate Update | MarketScreener
VANCOUVER, BC / January 6, 2020 / CVR Medical Corp. a Canadian listed and US based healthcare company in the medical device sector provides the following updates: … | January 6, 2020

US’ CEL-SCI Corporation closes $5.5m underwritten offering
Mubasher: American biotechnology company CEL-SCI Corporation has announced that it closed an underwritten public offering of 606,395 shares of its common stock.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35.38
Shares Float (M) 33.51
% Held by Insiders 4.61
% Held by Institutions 20.96
Shares Short (K) 6660
Shares Short P. Month (K)

Stock Financials

EPS -0.710
Book Value (p.s.) 0.150
PEG Ratio
Profit Margin
Operating Margin -4364.11
Return on Assets (ttm) -44.1
Return on Equity (ttm) -862.2
Qtrly Rev. Growth -57.3
Gross Profit (p.s.) -0.345
Sales Per Share
EBITDA (p.s.) -0.553
Qtrly Earnings Growth
Operating Cash Flow (M) -16.32
Levered Free Cash Flow (M) -14.47

Stock Valuations

P/E -19.66
P/E Growth Ratio -0.01
P/BV 93.07
P/S 1395.99
P/CF -30.26

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date 1996-08-27
Forward Dividend
Last Split Date 2017-06-14
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.